BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 641357)

  • 1. Complement fixation antibodies to glycosphingolipids in sera of rare blood group p and Pk phenotypes.
    Kato M; Kubo S; Naiki M
    J Immunogenet; 1978 Feb; 5(1):31-40. PubMed ID: 641357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunochemical study of the human blood group P1, P, and PK glycosphingolipid antigens.
    Naiki M; Marcus DM
    Biochemistry; 1975 Nov; 14(22):4837-41. PubMed ID: 1182122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical relationship between Forssman and globoside glycolipid antigens.
    Karol RA; Kundu SK; Marcus DM
    Immunol Commun; 1981; 10(3):237-50. PubMed ID: 7037611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical observations on the human blood group P system.
    Watkins WM; Morgan WT
    J Immunogenet; 1976 Feb; 3(1):15-27. PubMed ID: 932463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of antibody to galactosyl(alpha 1 leads to 4)galactosyl(beta 1 leads to 4)glucosylceramide.
    Clarke JT; Embil JA
    Biochim Biophys Acta; 1979 Jan; 582(2):283-94. PubMed ID: 760826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two kinds of P-fimbrial variants of uropathogenic Escherichia coli recognizing forssman glycosphingolipid.
    Orino K; Naiki M
    Microbiol Immunol; 1990; 34(7):607-15. PubMed ID: 1702504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in the glycosphingolipid content of human Pk and p erythrocytes.
    Marcus DM; Naiki M; Kundu SK
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3263-7. PubMed ID: 1067617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism for the biosynthesis of Forssman glycolipid from trihexosylceramide.
    Kijimoto-Ochiai S; Yokosawa N; Makita A
    J Biol Chem; 1980 Oct; 255(19):9037-40. PubMed ID: 6773959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological identification of blood group Pk antigen on normal human erythrocytes and isolation of anti-Pk with different affinity.
    Naiki M; Kato M
    Vox Sang; 1979; 37(1):30-8. PubMed ID: 494578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome agglutination and liposomal membrane immune-damage assays for the characterization of antibodies to glycosphingolipids.
    Uemura K; Yuzawa-Watanabe M; Kitazawa N; Taketomi T
    J Biochem; 1980 Jun; 87(6):1641-8. PubMed ID: 7190563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the human erythrocyte blood group P1 glycosphingolipid.
    Naiki M; Fong J; Ledeen R; Marcus DM
    Biochemistry; 1975 Nov; 14(22):4831-7. PubMed ID: 1182121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor.
    Teneberg S; Lönnroth I; Torres López JF; Galili U; Halvarsson MO; Angström J; Karlsson KA
    Glycobiology; 1996 Sep; 6(6):599-609. PubMed ID: 8922955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glycosphingolipid composition of the placenta of a blood group P fetus delivered by a blood group Pk1 woman and analysis of the anti-globoside antibodies found in maternal serum.
    Hansson GC; Wazniowska K; Rock JA; Ness PM; Kickler TS; Shirey RS; Niebyl JR; Zopf D
    Arch Biochem Biophys; 1988 Jan; 260(1):168-76. PubMed ID: 3341739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of N-acetylgalactosamine-containing compounds by a human IgM paraprotein.
    Naiki M; Marcus DM
    J Immunol; 1977 Aug; 119(2):537-9. PubMed ID: 886186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
    Ilyas AA; Mithen FA; Chen ZW; Cook SD
    J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The parasitic trematode Fasciola hepatica exhibits mammalian-type glycolipids as well as Gal(beta1-6)Gal-terminating glycolipids that account for cestode serological cross-reactivity.
    Wuhrer M; Grimm C; Dennis RD; Idris MA; Geyer R
    Glycobiology; 2004 Feb; 14(2):115-26. PubMed ID: 14638629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain.
    Young WW; Portoukalian J; Hakomori S
    J Biol Chem; 1981 Nov; 256(21):10967-72. PubMed ID: 7287743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal glycolipid composition of erythrocytes with a weak P antigen.
    Kundu SK; Steane SM; Bloom JE; Marcus DM
    Vox Sang; 1978 Sep; 35(3):160-7. PubMed ID: 676244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificities of human heterophile Hanganutziu and Deicher (HD) antibodies to glycosphingolipids and a glycoprotein.
    Mukuria CJ; Fujii Y; Kato S; Naiki M
    J Biochem; 1986 Aug; 100(2):469-75. PubMed ID: 3491066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new glycolipid antigen isolated from human erythrocyte membranes reacting with antibodies directed to globo-N-tetraosylceramide (globoside).
    Kannagi R; Fukuda MN; Hakomori S
    J Biol Chem; 1982 Apr; 257(8):4438-42. PubMed ID: 7068643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.